Home Innovation That Matters

Innovation That Matters

Brave Science: Putting the ‘Hutzpah’ in Early-Stage Drug Discovery

By Rich Soll, SVP of Research Service Division at WuXi AppTec (@richsollwx) From developing new paradigms for early-stage drug discovery for rare and common diseases to fostering the convergence of peptide nanotechnology, and launching scientific experiments in space, Israeli biochemist Ehud Gazit is wearing many hats these days. In...

Improving the Odds in Cancer With First-Time Immunotherapies

By Rich Soll, Senior Vice President, Research Service Division, WuXi AppTec (@richsollwx) With a strong belief that precision medicine is the future backbone of medicine, combined with advancements in the cancer immunotherapy field, and a unique platform, four-year-old Cambridge, Mass. biotech player Jounce Therapeutics is...

A Passion for Precision Medicines: How Three Start-ups Are Changing the Paradigm

By Hui Cai, Vice President of Corporate Alliances and Head of Corporate Communications, WuXi AppTec Troy Wilson jokes about time travel being the basis of his next company, and it’s with good reason. A serial entrepreneur, he has been remarkably productive over the last several years,...

Inside Perspectives: Gene Editing Takes Center Stage

Depending on the scientific expert, gene editing is just another sophisticated gene therapy tool in the fight against human diseases or a technological advance so remarkable it has the potential to change the course of human development and that of every other genus and...

Inside Perspectives on Gene Editing: An Interview with Genomics Pioneer George M. Church of Harvard University

Harvard University’s George M. Church is among the world’s leading scientific pioneers in genomics and biotechnology. The genetics professor at Harvard Medical School and Massachusetts Institute of Technology has founded numerous biotech companies that apply his breakthrough technological innovations to medical diagnostics, therapeutics, and synthetic biology.  Church...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi AppTec Acquires ResearchPoint Global to Better Enable Clinical Development Worldwide

We are pleased to announce that WuXi has acquired ResearchPoint Global (RPG), a U..S-based contract research organization (CRO) with expertise spanning across all major...